Business Description
Oncolytics Biotech Inc
NAICS : 325412
SIC : 3741
ISIN : CA6823108759
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 82.53 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 7.3 | |||||
3-Year EPS without NRI Growth Rate | 10.4 | |||||
3-Year FCF Growth Rate | 8.4 | |||||
3-Year Book Growth Rate | -11.6 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.2 | |||||
9-Day RSI | 46.92 | |||||
14-Day RSI | 48.86 | |||||
6-1 Month Momentum % | -35.51 | |||||
12-1 Month Momentum % | -13.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.01 | |||||
Quick Ratio | 9.01 | |||||
Cash Ratio | 8.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.3 | |||||
Shareholder Yield % | -28.73 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -105.86 | |||||
ROA % | -73.21 | |||||
ROIC % | -933.27 | |||||
ROC (Joel Greenblatt) % | -1923.66 | |||||
ROCE % | -101.65 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.95 | |||||
Price-to-Tangible-Book | 3.95 | |||||
EV-to-EBIT | -2.24 | |||||
EV-to-Forward-EBIT | -3.17 | |||||
EV-to-EBITDA | -2.26 | |||||
EV-to-Forward-EBITDA | -1.21 | |||||
EV-to-Forward-Revenue | 25.21 | |||||
EV-to-FCF | -2.66 | |||||
Price-to-Net-Current-Asset-Value | 4.06 | |||||
Price-to-Net-Cash | 4.56 | |||||
Earnings Yield (Greenblatt) % | -44.64 | |||||
FCF Yield % | -25.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Oncolytics Biotech Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.411 | ||
Beta | 1.12 | ||
Volatility % | 73.7 | ||
14-Day RSI | 48.86 | ||
14-Day ATR (C$) | 0.080609 | ||
20-Day SMA (C$) | 1.48 | ||
12-1 Month Momentum % | -13.75 | ||
52-Week Range (C$) | 1.2 - 4.49 | ||
Shares Outstanding (Mil) | 75.42 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Oncolytics Biotech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Oncolytics Biotech Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Oncolytics Biotech Inc Frequently Asked Questions
What is Oncolytics Biotech Inc(TSX:ONC)'s stock price today?
When is next earnings date of Oncolytics Biotech Inc(TSX:ONC)?
Does Oncolytics Biotech Inc(TSX:ONC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |